VIRAMUNE XR nevirapine 400 mg extended-release tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: eebc1781cb7f44c8
Product Name: VIRAMUNE XR nevirapine 400 mg extended-release tablet blister pack
Artg Id: 176980
Artg Name: VIRAMUNE XR nevirapine 400 mg extended-release tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2012-01-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/7d288d0aab170a3a3e7b826ea20f8d68.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/27c87710f64004f4becddfbbc63d538c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

eebc1781cb7f44c8

Type

Standard